Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | BACE1 | P56817 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.38 |
| ▸ | PPARG | P37231 | 2/20 | 0.38 |
| ▸ | PPARD | Q03181 | 2/20 | 0.38 |
| ▸ | PPARA | Q07869 | 2/20 | 0.38 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.38 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.38 |
| ▸ | TLR2 | O60603 | 1/20 | 0.38 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cetyl Alcohol SCHEMBL3813721 | 1.00 | LMNA (0.48) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| Dodecanol SCHEMBL27448108 | 1.00 | LMNA (0.48) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| Sorbic Acid SCHEMBL27992236 | 0.92 | ACHE (0.49) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| Sorbic Acid SCHEMBL13734143 | 0.92 | ACHE (0.52) | ALDH1A1TSHRHSD17B10MEN1KMT2A | |
| Sorbic Acid SCHEMBL13734145 | 0.92 | ACHE (0.52) | ALDH1A1TSHRHSD17B10MEN1KMT2A | |
| Sorbic Acid SCHEMBL28249602 | 0.92 | GPR84 (0.39) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| Sorbic Acid SCHEMBL28536418 | 0.90 | ACHE (0.40) | TSHRPTPN1ACHEBACE1HCAR2 | |
| Decanol SCHEMBL9136433 | 0.86 | TSHR (0.54) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| Sorbic Acid SCHEMBL28468693 | 0.86 | ACHE (0.40) | TSHRPTPN1ACHEBACE1HCAR2 | |
| Sorbic Acid SCHEMBL9156387 | 0.86 | ACHE (0.53) | PTPN1ACHEBACE1HCAR2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107308130-B | Coated drug spheroids and use to eliminate or reduce conditions such as emesis and diarrhea | 惠氏有限责任公司 | 2021-06-15 | — | — | CN | disclosed |
| CN-106074445-B | The purposes of the drug of illness is eliminated or is reduced in coated drugs orbicule and its preparation | 惠氏有限责任公司 | 2018-12-21 | — | — | CN | disclosed |
| CN-107441058-A | Coated drugs orbicule and elimination reduce illness such as the purposes vomitted and suffered from diarrhoea | 惠氏有限责任公司 | 2017-12-08 | — | — | CN | disclosed |
| CN-107308130-A | Coated drugs orbicule and elimination reduce illness such as the purposes vomitted and suffered from diarrhoea | 惠氏有限责任公司 | 2017-11-03 | — | — | CN | disclosed |
| US-8765717-B2 | Meloxicam and glucosamine formulation and uses thereof | MONTE VERDE S.A. (AR) | 2014-07-01 | — | — | US | disclosed |
| US-20100004200-A1 | MELOXICAM AND GLUCOSAMINE FORMULATION AND USES THEREOF | MONTE VERDE S.A. (AR) | 2010-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100004200-A1 | MELOXICAM AND GLUCOSAMINE FORMULATION AND USES THEREOF | MGAM, FUT6, CSGALNACT1 | LMNA 1913/4885ALDH1A1 2248/4885TSHR 2198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.